CCCheng-Ze Chen

Cheng-Ze Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cheng-Ze Chen has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Bang-Yi Lin

    Department of Surgical Oncology The First Affiliated Hospital of Wenzhou Medical University Wenzhou China

    2 shared publications
  • Jialiang Wen

    Department of Thyroid and Breast Surgery The First Affiliated Hospital of Wenzhou Medical University Wenzhou PR China

    2 shared publications
  • Jinmiao Qu

    Department of thyroid surgery, the first affiliated hospital of Wenzhou Medical University, Wenzhou, 325035, China

    2 shared publications
  • Chen Zheng

    Department of Thyroid & Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, PR China

    1 shared publication
  • Chen Zheng

    Department of Surgical Oncology The First Affiliated Hospital of Wenzhou Medical University Wenzhou China

    1 shared publication
  • Li‐Zhi Lin

    Department of Surgical Oncology The First Affiliated Hospital of Wenzhou Medical University Wenzhou China

    1 shared publication

Latest Publications

  • Open Access

    Eva‐1 homolog A promotes papillary thyroid cancer progression and epithelial‐mesenchymal transition via the Hippo signalling pathway

    by Bang‐Yi Lin, Jia‐Liang Wen, Chen Zheng, Li‐Zhi Lin, Cheng‐Ze Chen, Jin‐Miao Qu

    Recently, the incidence of thyroid cancer is increasing worldwide. Papillary thyroid cancer (PTC) is the most common histological type of thyroid cancer. Whole‐transcriptome sequence analysis was performed to further understand the primary molecular mechanisms of the occurrence and progression of PTC. Results showed that Eva‐1 homolog A (EVA1A) may be a potential gene for the PTC‐associated gene in thyroid cancer. In this work, the role of EVA1A expression in thyroid cancer was investigated. Real‐time PCR was performed to detect the expression level of EVA1A in 43 pairs of PTC and four thyroid cancer cell lines. The Cancer Genome Atlas (TCGA) database was used to evaluate the relationship between the expression level of EVA1A and the pathological feature of PTC. The logistic regression analysis of the TCGA data set indicated that the expression of EVA1A was an independent risk factor for tumour, nde and metastasis (TNM) in PTC. This study shows the down‐regulation of EVA1A inhibited the colony formation, proliferation, migration and invasion of PTC cell lines. In the protein level, knockdown of EVA1A can regulate the expression of N‐cadherin, vimentin, Bcl‐xL, Bax, YAP and TAZ. This study indicated that EVA1A was an oncogene associated with PTC.


  • Loc389641 Promotes Papillary Thyroid Cancer Progression by Regulating the Emt Pathway

    by Cheng-Ze Chen, Jia-Liang Wen, Bang-Yi Lin, Chen Zheng, Rui-Da Quan, Xiao-Hua Zhang, Jin-Miao Qu

    Aim: Thyroid cancer (TC) is one of the most common types of endocrine malignancy and poses a significant challenge to human health. The long noncoding RNA 389641 (LOC389641) has been found to be as...